• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
scissor cutting rope
Pharma

Merck will reduce workforce by 8%, laying off 6,000

Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey drugmaker told Fierce Pharma.
Kevin Dunleavy Jul 31, 2025 2:42pm
Regeneron

Issues at Novo Nordisk’s Indiana site trip up Regeneron again

Aug 1, 2025 11:51am
Moderna

Moderna recorded better-than-expected COVID shot sales in Q2

Aug 1, 2025 11:00am
very busy graphic of scientists working on an eye with one standing on a ladder preparing drops another set to apply a cont

Lenz's Vizz wins FDA approval to crack large presbyopia market

Aug 1, 2025 10:45am
Johnson  Johnson 3rd opinion lung cancer campaign

J&J coins the term ‘3rd opinion’ to empower lung cancer patients

Aug 1, 2025 10:38am
Merz Aesthetics sales and marketing executives

Merz Aesthetics gives sales and marketing leadership a face-lift

Aug 1, 2025 9:35am
More News

Untangling Sarepta’s gene therapy fallout

Aug 1, 2025 9:07am

GSK-Hengrui, Takeda, Celltrion—Fierce Pharma Asia

Aug 1, 2025 9:00am

Alnylam's market cap jumps past $50B

Aug 1, 2025 7:39am

'We've run scenarios': European pharmas relaxed about EU tariffs

Aug 1, 2025 2:30am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings